Second Entry Wins Approval as Hepatitis C Drug
Monday, May 23, 2011 - 15:10
in Health & Medicine
Vertex Pharmaceuticals will enter a marketing battle with Merck over new drugs that are expected to improve the cure rate of the viral disease and shorten the treatment duration.